Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification

被引:227
作者
Yang, XB
Roach, HI
Clarke, NMP
Howdle, SM
Quirk, R
Shakesheff, KM
Oreffo, ROC
机构
[1] Univ Southampton, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England
[2] Sch Pharmaceut Sci, Nottingham, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
human; osteoprogenitor; bone marrow; biodegradable polymer; poly(-lactic-co- glycolic acid) (PLGA); tissue engineering;
D O I
10.1016/S8756-3282(01)00617-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ability to generate new bone for skeletal use is a major clinical need. Biomimetic scaffolds that interact and promote osteoblast differentiation and osteogenesis offer a promising approach to the generation of skeletal tissue to resolve this major health-care issue. In this study we examine the ability of surface-modified poly(lactic acid) (PLA) films and poly(lactic-co-divided by glycolic acid) (PLGA) (75:25) porous structures to promote human osteoprogenitor adhesion, spreading, growth, and differentiation. Cell spreading and adhesion were examined using Cell Tracker green fluorescence and confocal microscopy. Osteogenic differentiation was confirmed with alkaline phosphatase activity as well as immunocytochemistry for type I collagen, core binding factor-1 (Cbfa-1), and osteocalcin. Poor cell growth was observed on nonmodified PLA films and PLGA scaffolds. The polymers were then coupled with RGD peptides [using poly(L-lysine), or PLL] and physical adsorption as well as PLA films presenting adsorbed fibronectin (FN). Both modifications enhanced cell attachment and spreading. On PLA-FN and PLA-PLL-GRGDS films, the osteoblast response was dose dependent (20 pmol/L to 0.2 mu mol/L FN and 30 nmol/L to 30 mu mol/L PLL-GRGDS) and significant at concentrations as low as 2 nmol/L FN and 30 nmol/L PLL-GRGDS. With optimal concentrations of FN or RGD, adhesion and cell spreading were comparable to tissue culture plastic serum controls. In PLGA (75:25) biodegradable porous scaffolds, coated with FN, PLL-GRGDS, or fetal calf serum for 24 h in alpha MEM alone, prior to growth in dexamethasone and ascorbate-2-phosphate for 4-6 weeks, extensive osteoblast impregnation was observed by confocal and fluorescence microscopy. Cell viability in extended culture was maintained as analyzed by expression of Cell Tracker green and negligible ethidium homodimer-1 (a marker of cell necrosis) staining. Alkaline phosphatase activity, type I collagen, Cbfa-1, and osteocalcin expression were observed by immunocytochemistry. Mineralization of collagenous matrix took place after 4 weeks, which confirmed the expression of the mature osteogenic phenotype. These observations demonstrate successful adhesion and growth of human osteoprogenitors on protein- and peptide-coupled polymer films as well as migration, expansion, and differentiation on three-dimensional biodegradable PLGA scaffolds. The use of peptides/proteins and three-dimensional structures that provide positional and environmental information indicate the potential for biomimetic structures coupled with appropriate factors in the development of protocols for de novo bone formation. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 48 条
[1]   Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen [J].
Bhatnagar, RS ;
Qian, JJ ;
Wedrychowska, A ;
Sadeghi, M ;
Wu, YM ;
Smith, N .
TISSUE ENGINEERING, 1999, 5 (01) :53-65
[2]  
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[3]  
2-F
[4]  
Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
[5]  
Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.0.CO
[6]  
2-F
[7]   An assessment of the strength of NG108-15 cell adhesion to chemically modified surfaces [J].
Cargill, RS ;
Dee, KC ;
Malcolm, S .
BIOMATERIALS, 1999, 20 (23-24) :2417-2425
[8]  
Chaput C., 1996, CURR OPIN ORTHOP, P62
[9]  
DALTON BA, 1995, J CELL SCI, V108, P2083
[10]   Fetuin/alpha 2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist [J].
Demetriou, M ;
Binkert, C ;
Sukhu, B ;
Tenenbaum, HC ;
Dennis, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12755-12761